The role of inflammatory cytokines in diabetic nephropathy

J Am Soc Nephrol. 2008 Mar;19(3):433-42. doi: 10.1681/ASN.2007091048. Epub 2008 Feb 6.

Abstract

Cytokines act as pleiotropic polypeptides regulating inflammatory and immune responses through actions on cells. They provide important signals in the pathophysiology of a range of diseases, including diabetes mellitus. Chronic low-grade inflammation and activation of the innate immune system are closely involved in the pathogenesis of diabetes and its microvascular complications. Inflammatory cytokines, mainly IL-1, IL-6, and IL-18, as well as TNF-alpha, are involved in the development and progression of diabetic nephropathy. In this context, cytokine genetics is of special interest to combinatorial polymorphisms among cytokine genes, their functional variations, and general susceptibility to diabetic nephropathy. Finally, the recognition of these molecules as significant pathogenic mediators in diabetic nephropathy leaves open the possibility of new potential therapeutic targets.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Cytokines / genetics
  • Cytokines / physiology*
  • Diabetic Nephropathies / drug therapy
  • Diabetic Nephropathies / genetics
  • Diabetic Nephropathies / physiopathology*
  • Humans

Substances

  • Anti-Inflammatory Agents
  • Cytokines